Comprehensive Epitranscriptome Analysis from MeRIP-seq Data with exomePeak2
As the most abundant internal RNA modification, N 6-methyladenosine (m6A) affects the fate of RNA through various mechanisms and regulates essential biological processes. In this study, we developed exomePeak2, a novel computational tool for the comprehensive analysis of the m6A epitranscriptome using data generated by Methylated RNA Immunoprecipitation Sequencing (MeRIP-seq), the most widely adopted method for transcriptome-wide profiling of m6A RNA methylation. With a novel statistical model that efficiently addresses the common GC content bias and the variable immunoprecipitation (IP) efficiency in MeRIP-seq data, exomePeak2 achieves state-of-the-art performance in m6A site detection (or peak calling) and differential methylation analysis compared to competing approaches. Additionally, exomePeak2 provides a number of critical functions for MeRIP-seq analysis, such as unraveling the dynamics of RNA methylation in an absolute sense, handling strand-specific libraries for clear discrimination of anti-sense transcripts, performing peak calling with or without a reference transcriptome, and motif-based methylation level quantification at near base-resolution. These capabilities enable more reliable and comprehensive epitranscriptome analysis of MeRIP-seq data. exomePeak2 is also applicable to techniques implementing similar working principles for other modifications, such as hMeRIP-seq for 5-hydroxymethylcytidine (hm5C) and acRIP-seq for N 4-acetylcytidine (ac4C). exomePeak2, together with a comprehensive MeRIP-seq analysis protocol, is freely available from GitHub: https://github.com/ZW-xjtlu/exomePeak2.
Authors
- Daniel J. Rigden (ORCID: https://orcid.org/0000-0002-7565-8937)
- Jingxian Zhou (ORCID: https://orcid.org/0000-0002-7847-798X)
- Di Zhen
- Y. Lynn Wang (ORCID: https://orcid.org/0000-0003-0773-1212)
- Jionglong Su (ORCID: https://orcid.org/0000-0001-5360-6493)
- Guifang Jia
- Frans Coenen
- Zhen Wei
- Jia Meng
Institutions
- Nanjing University of Chinese Medicine (CN)
- Harvard University (US)
- University of Liverpool (GB)
- Beijing National Laboratory for Molecular Sciences (CN)
- Xi’an Jiaotong-Liverpool University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Genomics Proteomics & Bioinformatics
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1093/gpbjnl/qzag019
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00